JMEE - ETF AI Analysis

Top Page

JPMorgan Market Expansion Enhanced Equity ETF (JMEE)

Rating:69Neutral

Price Target:―

JMEE, the JPMorgan Market Expansion Enhanced Equity ETF, has a solid overall rating driven mainly by strong, growth-focused holdings like United Therapeutics and Woodward, which show robust financial performance, positive earnings calls, and supportive technical trends. Additional contributors such as Ciena, MasTec, and nVent Electric add to the fund’s appeal with growth and strategic initiatives, though their higher valuations and, in some cases, weaker technical momentum introduce risk. The main risk factor is that several key holdings share themes of high valuation and profitability or cash flow challenges, which could make the ETF more sensitive to market pullbacks or shifts in investor sentiment toward growth stocks.

Positive Factors

Solid Recent Performance

The ETF has shown strong gains over the past three and twelve months, indicating positive recent momentum.

Broad Sector Diversification

Holdings are spread across many sectors such as industrials, financials, technology, and consumer-related areas, which helps reduce the impact of weakness in any single industry.

Growing Asset Base with Moderate Fees

The fund manages a sizable pool of assets with a relatively low expense ratio for an actively managed strategy, suggesting investor confidence while keeping ongoing costs reasonable.

Negative Factors

Heavy U.S. Concentration

With nearly all assets invested in U.S. companies, the ETF offers very limited geographic diversification and is highly tied to the U.S. market.

Small Individual Position Sizes

Top holdings each make up only a small slice of the portfolio, which can dilute the impact of its strongest-performing stocks on overall returns.

Mixed Performance Among Top Holdings

While several leading positions have delivered strong gains, a few key holdings have shown weaker or negative performance, which can drag on the fund’s overall results.

JMEE vs. SPDR S&P 500 ETF (SPY)

AUM2.33B

RegionNorth America

Expense Ratio0.24%

Beta0.93

IssuerJPMorgan

Inception DateMay 06, 2022

Dividend Yield1.03%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume115,895

30 Day Avg. Volume105,765

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

78.59

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering653

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

JMEE Summary

JMEE is the JPMorgan Market Expansion Enhanced Equity ETF, focused on the “extended market,” mainly mid-size and smaller U.S. companies rather than the big household-name giants. It does not track a set index, but instead uses JPMorgan’s research to pick a wide mix of stocks across many sectors, including industrials, financials, and technology. Well-known holdings include companies like Ciena and United Therapeutics. Someone might invest in JMEE to seek extra growth and diversification beyond large-cap funds. A key risk is that mid- and small-cap stocks can be more volatile and can go up and down more than the overall market.

How much will it cost me?The expense ratio for the JPMorgan Market Expansion Enhanced Equity ETF (JMEE) is 0.24%, which means you’ll pay $2.40 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as it uses JPMorgan's strategies to enhance returns while keeping costs relatively low.

What would affect this ETF?JMEE's focus on U.S. mid-cap and small-cap companies could benefit from economic growth and innovation in sectors like technology and industrials, which are key areas of exposure for the ETF. However, it may face challenges during periods of economic uncertainty or rising interest rates, which can negatively impact smaller companies and sectors like real estate and consumer cyclical. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings.

JMEE Top 10 Holdings

JMEE leans heavily into U.S. mid- and small-cap industrials and tech, and that’s where much of the action is. Defense and aerospace name Curtiss-Wright, along with Woodward and infrastructure player MasTec, have been rising and quietly pulling the fund forward. On the tech side, optical and communications plays like Coherent and Ciena have also been climbing, giving the ETF a growth-tilted engine. Offsetting some of that strength, United Therapeutics and Lumentum have been more mixed lately, occasionally tapping the brakes on overall performance.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
	―	2.07%	$48.32M	―	―	―
CIEN	Ciena	0.79%	$18.40M	$42.99B	238.44%	70 Outperform
LITE	Lumentum Holdings	0.77%	$17.96M	$40.18B	624.43%	61 Neutral
COHR	Coherent Corp	0.75%	$17.39M	$40.73B	150.26%	66 Neutral
WWD	Woodward	0.70%	$16.39M	$22.62B	103.39%	79 Outperform
CW	Curtiss-Wright	0.70%	$16.20M	$25.23B	111.70%	74 Outperform
UTHR	United Therapeutics	0.65%	$15.05M	$20.39B	27.82%	79 Outperform
NVT	nVent Electric	0.59%	$13.63M	$18.27B	65.74%	76 Outperform
MTZ	MasTec	0.57%	$13.17M	$21.27B	98.50%	74 Outperform
RS	Reliance Steel	0.54%	$12.68M	$17.96B	15.36%	74 Outperform

JMEE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

66.97

Positive

100DMA

64.81

Positive

200DMA

62.02

Positive

Market Momentum

MACD

0.92

Negative

RSI

63.42

Neutral

STOCH

70.01

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JMEE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 68.78, equal to the 50-day MA of 66.97, and equal to the 200-day MA of 62.02, indicating a bullish trend. The MACD of 0.92 indicates Negative momentum. The RSI at 63.42 is Neutral, neither overbought nor oversold. The STOCH value of 70.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JMEE.

JMEE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
JMEE	―	―	$2.33B	0.24%	―
CGUS	―	―	$8.84B	0.33%	―
QQQI	―	―	$8.63B	0.68%	―
CGMM	―	―	$1.52B	0.51%	―
TMSL	―	―	$1.51B	0.55%	―
SMIG	―	―	$1.26B	0.60%	―

Performance Comparison

JMEE

JPMorgan Market Expansion Enhanced Equity ETF

70.18

8.69

14.13%

CGUS

Capital Group Core Equity ETF

―

QQQI

NEOS Nasdaq 100 High Income ETF

―

CGMM

Capital Group U.S. Small and Mid Cap ETF

―

TMSL

T. Rowe Price Small-Mid Cap ETF

―

SMIG

AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents